MFG
ADMA icon

Merit Financial Group’s ADMA Biologics ADMA Stock Holding History

Merit Financial Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718K Buy
85,750
+11,306
+15% +$103K ﹤0.01% 1273
2026
Q1 		$671K Buy
74,444
+63,850
+603% +$1.01M 0.01% 1194
2025
Q4 		$193K Buy
+10,594
New +$179K ﹤0.01% 1831

Other funds holding ADMA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Merit Financial Group's ADMA Position: Q2 2026 in Review

Merit Financial Group increased its ADMA Biologics (ADMA) stake by 15% in Q2 2026, buying an estimated $103K and bringing the position to 85,750 shares worth $718K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Merit Financial Group first reported a position in ADMA in Q4 2025 and has held it in 3 quarters since. 41 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Merit Financial Group held 85,750 shares of ADMA Biologics worth $718K as of Q2 2026.
  • Merit Financial Group bought 11,306 ADMA Biologics shares in Q2 2026, an estimated $103K.
  • ADMA Biologics made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1273 holding.
  • Merit Financial Group first reported a position in ADMA Biologics in Q4 2025 and has held it in 3 quarters since.
  • 41 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.